Delivery Order SPE2DB22D1106-SPE2DB24FDYZ4

Award Date 2/6/24
Potential Completion Date 2/7/24
Potential Value $1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $1,478.36 firm fixed price delivery order from the Defense Logistics Agency (DLA) to provide CLOMID 50 MG TABLET UD 30S. This delivery order has a completion date of March 5, 2024. Amerisourcebergen Drug Corp serves as a prime contractor to the DLA Troop Support Medical, providing pharmaceuticals, medical supplies, and related distribution services in support of military treatment programs and facilities....
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $3,053.28 firm fixed price delivery order by the Defense Logistics Agency to provide CLOMID 50 MG TABLET UD 30S. The contract has a completion date of February 7, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical for the provision of CLOMID 50 MG TABLET UD 30S with a potential value of $2,081.61. The contract has a completion date of January 31, 2024. Amerisourcebergen Drug Corp is the prime contractor on this contract, which is not designated as a set-aside. Additionally, Amerisourcebergen Drug Corp holds an...
Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order against their indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical. Valued at $2,641.65, this order is for the supply of 4562927075 CLOMID 50 MG TABLET UD 30S to the DLA Troop Support Medical program. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by November 29, 2023. No set-aside designation was applied to this...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $7,703.57 delivery order is for the supply of CLOMID 50 MG TABLET UD 30S, a prescription drug used in medical treatments. The contract has a firm fixed price and an ultimate completion date of August 30, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this delivery order as part of a larger Indefinite...
This federal contract award is a delivery order placed with Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,306.18, is to supply CLOMID 50 MG TABLET UD 30S to the Defense Logistics Agency (DLA), a defense agency. The contract has a firm fixed price pricing type and an ultimate completion date of December 24, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) has awarded a Delivery Order contract worth $1,675.07 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of CLOMID 50 MG TABLET UD 30S. This contract has a performance period through July 23, 2024 and is a Firm Fixed Price arrangement. The contract supports the healthcare needs of military treatment facilities and other federal beneficiaries. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,126.96 firm fixed-price delivery order is for the supply of CLOMID 50 MG TABLET UD 30S, a pharmaceutical product. The contract has an ultimate completion date of February 25, 2025 and was awarded on February 24, 2025. The contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, a firm fixed price delivery order valued at $1,112.79, is for the supply of CLOMID 50 MG TABLET UD 30S, a pharmaceutical product. This delivery order does not have a set-aside designation and is part of a larger indefinite delivery contract (IDC) between...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of CLOMID 50 MG TABLET UD 30S, a prescription medication. The award, valued at $1,122.45, was made on August 27, 2024, with a completion date of August 28, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999, which enables the agency to efficiently procure a comprehensive range of...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FDYZ4
    Delivery Order

Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract valued at $1,029.12 by the Defense Logistics Agency (DLA) to provide 4563574733 ! CLOMID 50 MG TABLET UD 30S. The contract has a performance period through February 7, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to military treatment programs and facilities worldwide.

Generated 5/7/24, 11:57 AM